Renaissance Technologies - AVANIR PHARMACEUTICALS INC ownership

AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 171 filers reported holding AVANIR PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AVANIR PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$14,993,000
+2066.6%
884,514
+1424.7%
0.04%
+1700.0%
Q3 2014$692,00058,0140.00%
Other shareholders
AVANIR PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 2,295,000$38,900,0006.85%
Baker Brothers Advisors 38,513,713$652,807,0006.66%
Realm Partners LLC 300,000$5,085,0003.92%
Miura Global Management 2,758,000$46,748,0003.52%
WATER ISLAND CAPITAL LLC 10,612,846$179,887,740,0003.00%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 641,056$10,866,0002.72%
Verition Fund Management LLC 703,900$11,931,0002.67%
GLAZER CAPITAL, LLC 1,004,815$17,032,0002.46%
GARDNER LEWIS ASSET MANAGEMENT L P 716,994$12,153,0002.45%
Rock Springs Capital Management LP 1,100,000$18,645,0002.18%
View complete list of AVANIR PHARMACEUTICALS INC shareholders